[NVAX] Still holding - Novavax is first "safe" COVID vaccineThis proved to the market and world governments that their nanotechnology is superior and that it works. Next stop, flu vaccine. I'm holding. Disclaimer: Not financial advice. Just my opinion. See my related posts. Source: www.cnn.comLongby traderman0011
NVAX Next moveWill NVAX finally bounce here? It sure is showing some major BULLISH divergence here on the 4H, the 2 week has test it's lower band, and momentum on the monthly is still very much bullish. We had to expect some kind of correction with months of hard bullish runs. With NVAX having to get through Phase 2./3 clinicals and FDA approval along with Fauci possibly accelerating that approval, there are some good catalyst to push this higher. $100 is a great entry for a 2x and 3x roi. High target on this is $300 for my personal position. Longby allout063
NVAX: Bullishtoo expensive for me :( perfect time for flu season panic Longby Chillin_Like_A_Villain3
Falling wedge $NVAX Gonna squeeze hard! . Watch it closely .$NVAX Gonna squeeze hard! . Watch it closely . Longby K-alonzi111
The trend is over for Novavax, Inc?What a run that was! From the Go signal in January at under $6, Novavax, Inc rallied all the way to $190. Now, however, the trend has changed. The GoNoGo Trend flagged a NoGo yesterday on the daily chart, after one neutral amber bar that suggested the Go trend was over. Early warning was given by the GoNoGo Oscillator, which on August 12th crossed below the zero line, indicating that momentum had turned negative for the first time in months. It was then turned away by the zero line a bar before the GoNoGo Trend painted the amber bar. The environment is bearish and further rejections at the zero line for the GoNoGo Oscillator would suggest a deeper NoGo trend.Shortby GoNoGoCharts2
NOVAVAX (Some Wild Prediction )This is a trend that I have drawn a while ago! Too bad that I did not publish as its wild and aggressive. by vrambatiUpdated 2
Fib looks good for the near futureFibonacci looks good for the short term. I think it will have a nice gap up soon. LONGLongby SlashFractal14
NVAX (1h Time Frame)Looking for price to give us a pullback into the $130 support (potential selling opportunities) but if we break to the upside @ $151.50, the closure would be what I need to then look at going long. I'm eyeing the $177-$182.50 for TP. #TechnicalAnalysis #FibonacciLongby UnknownUnicorn45576874
Novovax could see gains after COVID-19 vaccine orders roll in90 million vaccines have just been purchased by the UK government and the US is also in talks to purchase COVID-19 vaccines.Longby James_Winsoar0
NVAX LONG D1 (extra entry)📈 LON G D1 🛒Risky entry (1%-2% risk) ~ 178.5 🛒A more reliable entry (2%-3% risk) = above 190.30 🎯Target1 = 209.5 🎯Target2 = 240.80 🛑Stop loss or cancel trade = 159Longby TradeHunt24Updated 662
WHOOOO WHEEEE - JPM Calling NVAX To 275 Today On Drug DataThis is one of the more insane calls I've seen of late. Last night NVAX released drug data which was interpreted as a huge positive, and thus the stock is rallying this morning, especially following a JPM call that the company's fair value is $275. That's quite a bit of headroom from where we are now, and also about 70% upside from yesterday's close. A quick look at the momentum suggests that we might actually get there, but personally I'm skeptical. I'm not convinced that the winner of the Covid - 19 virus race will actually rake in profits from it, given how political finding the cure is, and how it seems unlikely that it will be sold for anything but at cost, probably around $10. Just some speculation. Definitely a situation to keep an eye on though. I''m looking for a slowing in momentum before shorting it.Shortby PropNotes448
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward. Things to watch even after COVID-19: - NanoFlu™ - ResVax™ - Recombinant Nanoparticle Vaccine Technology - Matrix-M™ Adjuvant Technolog TL;DR - To the moon and (probably) back lol *Note: This is pure speculation and my own opinion* NY Times: www.nytimes.com CNBC: www.cnbc.comLongby traderman001Updated 226
NVAX LONG📈 NVAX LONG D1 🛒BUY above = 156 🎯Target1 = 172 🎯Target2 = 201 🛑Stop loss = 1126 🙈Risk = (1%-2%) #NVAX #NVAXLONG #BUYNVAXLongby TradeHunt24Updated 4
highly volatilehave upcoming earnings double topped below vwap support at 9ema expecting break to retest bullish channel entry 100.28 stop loss 95 target >109 Risk/Reward -5/>+9 by thewrongdip5
Novamax Inc (NVAX - NASDAQ) - Bulls in driving seat Novamax Inc (NVAX - NASDAQ) is in 3rd subwave of impulse sequence, where log scale is used to understand the wave structure. It is in 3rd internal wave of 3rd subwave of impulse. Buy in three wave pull back in appropriate waves. The gap in price with huge volume driving it up crazy.Longby EWFcw667
$NVAX rising wedge forming on the dailyThere is a rising wedge forming on $NVAX daily chart. Bio stocks could break out to the topside with any news but this is a very bearish reversal pattern. Look for a play when it breaks the trend either way. Gap to the lower end could be filled. Shortby poetic1444
NVAX'S VACCINE FOR FLU IS PROMISING! Hello traders! Good news from Novavax! The chances of approval for flu vaccine candidate NanoFlu seems actually quite good! Moreover, if we look at the chart, we can see that the price is on a strong uptrend that doesn't seem to want to stop. The bullish momentum is still strong! Remember to put a stop loss in order to secure your capital! Not a financial advice. Enjoy your trade! Longby vf_investment8
NOVAVAX announcementHey guys, NOVAVAX is in a compression zone, sinal to purchase high volume of sales in recent days. It may break the balance area from above at the same time, great hope of breaking out the second area while passing. Please LIKE & FOLLOW, thank you! Shortby stephanelibatd115
Novavax Announces $1.6 Billion Funding from Operation Warp SpeedNovavax Announces $1.6 Billion Funding from Operation Warp Speed has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021. Novavax has been awarded $1.6 billion by the federal government to complete late-stage clinical development, including a pivotal Phase 3 clinical trial; establish large-scale manufacturing; and deliver 100 million doses of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate, as early as late 2020. NVX‑CoV2373 consists of a stable, prefusion protein made using its proprietary nanoparticle technology and includes Novavax’ proprietary Matrix‑M™ adjuvant. by AlenCiken113
Nvax to Receive up to $388 Million Funding from CEPI CASE STUDY1. Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing -Funds clinical development of NVX-CoV2373 through Phase 2 -Supports rapid scale-up of vaccine manufacturing -Allows for increased production of Matrix-M adjuvant -Reserves global large-scale manufacturing capacity A Phase 1/2 clinical trial with the Phase I portion starting this month in Australia and the Phase 2 portion conducted in multiple countries following successful Phase 1 top-line results that are expected in July. ir.novavax.com 2. Novavax Reports First Quarter 2020 Financial Results -CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturing -NVX‑CoV2373 Phase I trial initiating in May with preliminary results in July -NanoFlu recently achieved all primary endpoints in pivotal Phase 3 clinical trial ir.novavax.comby AlenCiken4